1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Julie Graff, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. Fecal microbiota transplant, Pembrolizumab, Enzalutamide - Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Unknown | Julie Graff, MD | 32 | 2019-10-30 | 2022-06-23 |
Neoplasm Metastasis (1) · Prostatic Neoplasms (1)
Fecal Microbiota Transplantation (1) · enzalutamide (1) · pembrolizumab (1)
United States (1)